ES2567803T3 - Aparato y método para el flujo lateral de ensayos de afinidad - Google Patents
Aparato y método para el flujo lateral de ensayos de afinidad Download PDFInfo
- Publication number
- ES2567803T3 ES2567803T3 ES12738592.0T ES12738592T ES2567803T3 ES 2567803 T3 ES2567803 T3 ES 2567803T3 ES 12738592 T ES12738592 T ES 12738592T ES 2567803 T3 ES2567803 T3 ES 2567803T3
- Authority
- ES
- Spain
- Prior art keywords
- molecule
- sample
- immobilized
- solid phase
- detector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 21
- 238000012360 testing method Methods 0.000 title description 21
- 239000007790 solid phase Substances 0.000 claims abstract description 28
- 108090000790 Enzymes Proteins 0.000 claims abstract description 22
- 102000004190 Enzymes Human genes 0.000 claims abstract description 22
- 239000012491 analyte Substances 0.000 claims abstract description 19
- 239000000758 substrate Substances 0.000 claims abstract description 18
- 238000004445 quantitative analysis Methods 0.000 claims abstract description 5
- 230000003993 interaction Effects 0.000 claims abstract description 3
- 239000000523 sample Substances 0.000 claims description 49
- 230000008859 change Effects 0.000 claims description 15
- 238000001514 detection method Methods 0.000 claims description 12
- 229920000642 polymer Polymers 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- 239000000427 antigen Substances 0.000 claims description 8
- 108091007433 antigens Proteins 0.000 claims description 8
- 102000036639 antigens Human genes 0.000 claims description 8
- 108010046334 Urease Proteins 0.000 claims description 6
- 239000004202 carbamide Substances 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 3
- 108090001008 Avidin Proteins 0.000 claims description 2
- 239000002702 enteric coating Substances 0.000 claims description 2
- 238000009505 enteric coating Methods 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 13
- 241000894007 species Species 0.000 description 11
- 238000003018 immunoassay Methods 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 102000009609 Pyrophosphatases Human genes 0.000 description 4
- 108010009413 Pyrophosphatases Proteins 0.000 description 4
- 238000002820 assay format Methods 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- GPRSOIDYHMXAGW-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopentanecarboxylic acid iron Chemical compound [CH-]1[CH-][CH-][C-]([CH-]1)C(=O)O.[CH-]1C=CC=C1.[Fe] GPRSOIDYHMXAGW-UHFFFAOYSA-N 0.000 description 4
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 4
- 235000011180 diphosphates Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 229920002301 cellulose acetate Polymers 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- -1 carboxymethyl ethyl Chemical group 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000003487 electrochemical reaction Methods 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000012123 point-of-care testing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003303 ruthenium Chemical class 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- BYGOPQKDHGXNCD-UHFFFAOYSA-N tripotassium;iron(3+);hexacyanide Chemical compound [K+].[K+].[K+].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] BYGOPQKDHGXNCD-UHFFFAOYSA-N 0.000 description 2
- HBZBAMXERPYTFS-SECBINFHSA-N (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)[C@H]1CSC(=N1)c1nc2cc3CCNc3cc2s1 HBZBAMXERPYTFS-SECBINFHSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108010031480 Artificial Receptors Proteins 0.000 description 1
- 108050001427 Avidin/streptavidin Proteins 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940063559 methacrylic acid Drugs 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000002907 osmium Chemical class 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 1
- FHCPAXDKURNIOZ-UHFFFAOYSA-N tetrathiafulvalene Chemical compound S1C=CSC1=C1SC=CS1 FHCPAXDKURNIOZ-UHFFFAOYSA-N 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 239000001016 thiazine dye Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201112395 | 2011-07-19 | ||
| GBGB1112395.7A GB201112395D0 (en) | 2011-07-19 | 2011-07-19 | Immunoassay |
| PCT/GB2012/051733 WO2013011323A2 (en) | 2011-07-19 | 2012-07-19 | Apparatus and method for affinity assays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2567803T3 true ES2567803T3 (es) | 2016-04-26 |
Family
ID=44586826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12738592.0T Active ES2567803T3 (es) | 2011-07-19 | 2012-07-19 | Aparato y método para el flujo lateral de ensayos de afinidad |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20140248642A1 (enExample) |
| EP (1) | EP2734842B1 (enExample) |
| JP (1) | JP6053781B2 (enExample) |
| DK (1) | DK2734842T3 (enExample) |
| ES (1) | ES2567803T3 (enExample) |
| GB (1) | GB201112395D0 (enExample) |
| WO (1) | WO2013011323A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105556307B (zh) | 2013-04-15 | 2019-07-05 | 南洋理工大学 | 电化学侧向流动生物测定和生物传感器 |
| US20170285021A1 (en) * | 2014-08-30 | 2017-10-05 | Agency For Science, Technology And Research | A Test Strip For Paper-Based Assay |
| US9678070B2 (en) | 2015-04-29 | 2017-06-13 | Church & Dwight Co., Inc. | Method and apparatus for electrochemical detection |
| EP3735315A4 (en) | 2018-01-05 | 2021-09-29 | SiMPore Inc. | SAMPLE PREPARATION AND FLOW SENSORS USING FUNCTIONALIZED SILICON MEMBRANES |
| CN110895283A (zh) * | 2019-12-10 | 2020-03-20 | 宁波奥丞生物科技有限公司 | 一种高灵敏度的d-二聚体检测试剂盒及其使用方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851337A (en) * | 1986-01-08 | 1989-07-25 | Hygeia Sciences, Inc. | Extraction of test substances |
| US5139934A (en) * | 1990-05-25 | 1992-08-18 | Becton, Dickinson And Company | Substrate composition and method for solid phase urease immunoassay |
| US5846744A (en) * | 1993-05-29 | 1998-12-08 | Cambridge Life Sciences Plc | Sensors based on polymer transformation |
| US20050287035A1 (en) * | 1997-06-04 | 2005-12-29 | Bernadette Yon-Hin | Electrode strips for testing small volumes |
| US7348183B2 (en) * | 2000-10-16 | 2008-03-25 | Board Of Trustees Of The University Of Arkansas | Self-contained microelectrochemical bioassay platforms and methods |
| AU2003262742A1 (en) * | 2002-08-19 | 2004-03-03 | Iowa State University Research Foundation, Inc. | Redox polymer nanoparticles |
| US20040106190A1 (en) * | 2002-12-03 | 2004-06-03 | Kimberly-Clark Worldwide, Inc. | Flow-through assay devices |
| US20050112703A1 (en) * | 2003-11-21 | 2005-05-26 | Kimberly-Clark Worldwide, Inc. | Membrane-based lateral flow assay devices that utilize phosphorescent detection |
| JP4007606B2 (ja) * | 2004-02-03 | 2007-11-14 | キヤノン株式会社 | センサおよび検出方法 |
| CN101031798B (zh) * | 2004-07-29 | 2012-06-27 | 瑞莱诊断体系有限公司 | 侧向流系统和测定 |
| US7776618B2 (en) | 2007-03-01 | 2010-08-17 | Church & Dwight Co., Inc. | Diagnostic detection device |
| WO2009021908A2 (en) * | 2007-08-10 | 2009-02-19 | Unilever Plc | Disposable enzymatic sensor for liquid samples |
-
2011
- 2011-07-19 GB GBGB1112395.7A patent/GB201112395D0/en not_active Ceased
-
2012
- 2012-07-19 JP JP2014520730A patent/JP6053781B2/ja not_active Expired - Fee Related
- 2012-07-19 WO PCT/GB2012/051733 patent/WO2013011323A2/en not_active Ceased
- 2012-07-19 US US14/233,233 patent/US20140248642A1/en not_active Abandoned
- 2012-07-19 DK DK12738592.0T patent/DK2734842T3/en active
- 2012-07-19 EP EP12738592.0A patent/EP2734842B1/en active Active
- 2012-07-19 ES ES12738592.0T patent/ES2567803T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB201112395D0 (en) | 2011-08-31 |
| JP6053781B2 (ja) | 2016-12-27 |
| US20140248642A1 (en) | 2014-09-04 |
| DK2734842T3 (en) | 2016-04-11 |
| EP2734842A2 (en) | 2014-05-28 |
| JP2014521102A (ja) | 2014-08-25 |
| EP2734842B1 (en) | 2016-01-20 |
| WO2013011323A2 (en) | 2013-01-24 |
| WO2013011323A3 (en) | 2013-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lin et al. | A nanoparticle label/immunochromatographic electrochemical biosensor for rapid and sensitive detection of prostate-specific antigen | |
| Solaimuthu et al. | Nano-biosensors and their relevance in tissue engineering | |
| Sinawang et al. | Electrochemical lateral flow immunosensor for detection and quantification of dengue NS1 protein | |
| Fernández-Sánchez et al. | Disposable noncompetitive immunosensor for free and total prostate-specific antigen based on capacitance measurement | |
| Ge et al. | Nanomaterial-enhanced paper-based biosensors | |
| CN103874924B (zh) | 通过一次的试样注入就能够依次改变反应条件的膜传感器 | |
| US20150241423A1 (en) | Immunoassay using electrochemical detection | |
| ES2567803T3 (es) | Aparato y método para el flujo lateral de ensayos de afinidad | |
| Medawar-Aguilar et al. | Serological diagnosis of Toxoplasmosis disease using a fluorescent immunosensor with chitosan-ZnO-nanoparticles | |
| ES2410754T3 (es) | Procedimiento para la detección electroquímica de reacciones de unión | |
| JPWO2003014740A1 (ja) | バイオセンサ、及び測定方法 | |
| Khristunova et al. | Electrochemical immunoassay for the detection of antibodies to tick-borne encephalitis virus by using various types of bioconjugates based on silver nanoparticles | |
| Nian et al. | Electrochemical immunoassay of cotinine in serum based on nanoparticle probe and immunochromatographic strip | |
| JP2009002939A (ja) | アンペロメトリック型バイオセンサ | |
| Wang et al. | A novel impedance enhancer for amperometric biosensor based ultrasensitive detection of matrix metalloproteinase-2 | |
| WO2015119386A1 (ko) | 효소 모방 무기 나노입자를 이용한 고감도 측면유동 면역 발색칩 및 이를 이용한 검출 방법 | |
| US20220163521A1 (en) | Paper lateral flow immunoassay | |
| Cetinkaya et al. | A comprehensive overview of sensors applications for the diagnosis of SARS-CoV-2 and of Drugs Used in its Treatment | |
| Wang et al. | A visual cardiovascular biomarker detection strategy based on distance as readout by the coffee-ring effect on microfluidic paper | |
| CN103278621A (zh) | 一种利用生物传感器与血糖仪检测转录因子的方法 | |
| Popov et al. | Ultra-sensitive electrochemical immunosensors for clinically important biomarker detection: Prospects, opportunities, and global trends | |
| Zhang et al. | Advances in rapid point-of-care virus testing | |
| Dong et al. | Universal all-in-one lateral flow immunoassay with triple signal amplification for ultrasensitive and simple self-testing of Treponema pallidum antibodies | |
| Lin et al. | Immobilized rolling circle amplification on extended-gate field-effect transistors with integrated readout circuits for early detection of platelet-derived growth factor | |
| Ming-Qing et al. | Research progress of C-reactive protein analysis |